Advanced serrated polyps as a target of screening: detection rate and positive predictive value within a fecal immunochemical test-based colorectal cancer screening population
Endoscopy · 01.06.2023 · 55 (06) · 526-534
DOI: 10.1055/a-1971-3488 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.06.2023. Verfasst von David E F W M van Toledo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Adenoma, Colonic Polyps. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Rijksinstituut voor Volksgezondheid en Milieu.
Abstract (Originalsprache)
Background
Advanced serrated polyps (ASPs) have a comparable risk to advanced adenomas for progression to colorectal cancer (CRC). The yield of most CRC screening programs, however, is based on advanced adenomas and CRC only. We assessed the ASP detection rate, and positive predictive value (PPV) including ASPs in a fecal immunochemical test (FIT)-based screening program.
Methods
We analyzed the findings of follow-up colonoscopies of FIT-positive screenees in the Dutch CRC screening program from 2014 until 2020. Data were retrieved from the national screening and pathology database. An ASP was defined as any serrated polyp of ≥ 10 mm, sessile serrated lesion with dysplasia, or traditional serrated adenoma. The ASP detection rate was defined as the proportion of colonoscopies with ≥ 1 ASP. PPV was originally defined as the proportion of individuals with a CRC or advanced adenoma. The updated PPV definition included CRCs, advanced adenomas, and/or ASPs.
Results
322 882 colonoscopies were included in the analyses. The overall detection rate of ASPs was 5.9 %. ASPs were detected more often in women than men (6.3 % vs. 5.6 %; P < 0.001). ASP detection rates in individuals aged 55–59, 60–64, 65–69, and 70 + were 5.2 %, 6.1 %, 6.1 %, and 5.9 %, respectively (P < 0.001). The PPV for CRCs and advanced adenomas was 41.1 % and increased to 43.8 % when including ASPs. The PPV increase was larger in women than in men (3.2 vs. 2.4 percentage points).
Conclusions
5.9 % of FIT-positive screenees had ASPs, but half of these were detected in combination with a CRC or advanced adenoma. Therefore, including ASPs results in a small increase in the yield of FIT-based screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
- Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands.
- Cancer Center Amsterdam, Amsterdam University Medical Centers, Location Academic Medical Center, Amsterdam, The Netherlands.
- Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
- Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
ORCID-Profile: Manon C W Spaander, Evelien Dekker
Förderung
- Rijksinstituut voor Volksgezondheid en Milieu
Zitieren
APA
van Toledo, D. E. F. W. M., Breekveldt, E. C. H., IJspeert, J. E. G., van Vuuren, A. J., van Kemenade, F. J., Ramakers, C., Nagtegaal, I. D., van Leerdam, M. E., Spaander, M. C. W., Lansdorp-Vogelaar, I., Toes-Zoutendijk, E., & Dekker, E. (2023). Advanced serrated polyps as a target of screening: detection rate and positive predictive value within a fecal immunochemical test-based colorectal cancer screening population. Endoscopy, 55(06), 526-534. https://doi.org/10.1055/a-1971-3488
Vancouver
van Toledo DEFWM, Breekveldt ECH, IJspeert JEG, van Vuuren AJ, van Kemenade FJ, Ramakers C, et al. Advanced serrated polyps as a target of screening: detection rate and positive predictive value within a fecal immunochemical test-based colorectal cancer screening population. Endoscopy. 2023;55(06):526-534. doi:10.1055/a-1971-3488
BibTeX
@article{vanToledo2023,
author = {van Toledo, David E F W M and Breekveldt, Emilie C H and IJspeert, Joep E G and van Vuuren, Anneke J and van Kemenade, Folkert J and Ramakers, Christian and Nagtegaal, Iris D and van Leerdam, Monique E and Spaander, Manon C W and Lansdorp-Vogelaar, Iris and Toes-Zoutendijk, Esther and Dekker, Evelien},
title = {Advanced serrated polyps as a target of screening: detection rate and positive predictive value within a fecal immunochemical test-based colorectal cancer screening population},
journal = {Endoscopy},
year = {2023},
volume = {55},
number = {06},
pages = {526--534},
doi = {10.1055/a-1971-3488}
}
EUVIMED